Drugs / Umbilical Cord Blood Infusion (Autologous and Allogeneic)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06995274 | Jun → Dec 2025 overdue | autism spectrum disorder, eosinophilic gastrointestinal disease | Bundang CHA Hospital | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Umbilical Cord Blood Infusion (Autologous and Allogeneic) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06995274 ↗ |
| Known as | UCB | “The intervention consists of three intravenous infusions of umbilical cord blood (UCB) in a pediatric patient diagnosed with both eosinophilic duodenitis (ED) and autism...” NCT06995274 ↗ |
| Route | Intravenous | “Each infusion is administered intravenously via peripheral vein” NCT06995274 ↗ |